Biotechnology / Medical Research

Senomyx Inc Issues FY 2013 Guidance In Line With Analysts' Estimates

Senomyx Inc announced that for fiscal 2013, it continues to expect total revenues of $31 million to $34 million, net loss of $8 million to $10 million and basic and diluted net loss of $0.20 to $0.25 per share. According to I/B/E/S Estimates, analysts on an average were expecting the Company to...

8:30am EDT

Ligand Pharmaceuticals Inc Reaffirms FY 2013 Guidance; Issues Q3 2013 Guidance; EPS Guidance Below Analysts' Estimates

Ligand Pharmaceuticals Inc announced that it is affirming its previous fiscal 2013 financial forecast, the Company expects total revenues to be between $43.0 million and $46.0 million, and non-GAAP earnings per diluted share to be between $0.47 and $0.51. For the third quarter of 2013, Ligand...

8:30am EDT

Astex Pharmaceuticals Inc Raises FY 2013 Revenue Guidance; Lowers FY 2013 Net Income Guidance

Astex Pharmaceuticals Inc announced that for fiscal 2013, revised from $55 million to $63 million, net loss has been reduced from the previous guidance of $30 million to a revised $25 million. According to I/B/E/S Estimates, analysts were expecting the Company to report revenue of $59 million and...

8:01am EDT

ViroPharma Inc Reaffirms FY 2013 Worldwide Net Product Sales Guidance

ViroPharma Inc announced that for fiscal 2013, it expects worldwide net product sales to be $440 million to $465 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $449 million for fiscal 2013.

7:30am EDT

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.